https://prabadinews.com/
  • October 8, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program

FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program

ISTAND supports innovative, science-driven approaches that improve drug development and regulatory decision-making, ultimately helping to make therapies available to address patients’ unmet needs.

administrator

Related Articles